Skip to main content
. 2017 Apr 26;118(1):595–609. doi: 10.1152/jn.00743.2016

Fig. 4.

Fig. 4.

Role of calmodulin in proctolin-induced IMI amplitude. Proctolin-induced IMI is shown at different concentrations of calmodulin inhibitors W7 (A) and calmidazolium (CDZ; B). A: quantification of W7 data. A 1-way repeated-measures ANOVA showed a small but significant reduction of proctolin-induced IMI amplitude by W7 [F(4,19) = 3.24, P = 0.035]. B: proctolin-induced IMI at different concentrations of CDZ. A 1-way repeated-measures ANOVA showed that CDZ reduced proctolin-induced IMI amplitude [F(3,9) = 6.38, P = 0.013]. Error bars are SE. Tukey test: *P < 0.05.